Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 33 matching records.
33 results — page 1 of 2
- Level DAnimal StudyPubMed
Safety and biodistribution of intrathecal administration of mesenchymal stem cells (MSCs) and neurotrophin-releasing nanoparticles in a porcine CSF-guided delivery model for amyotrophic lateral sclerosis (ALS) drug disco
Animal Study on Neuroinflammation, Chronic Inflammation, published in Sci Rep (2026) — summary generated from the PubMed abstract.
- 2026
Sci Rep - Level DAnimal StudyPubMed
Therapeutic potential of adipose-derived stem cell transplantation in amyotrophic lateral sclerosis: A combined clinical case and preclinical study.
Animal Study on Neuroinflammation, published in Tzu Chi Med J (2026) — summary generated from the PubMed abstract.
- 2026
Tzu Chi Med J - Level DAnimal StudyEurope PMC
Brown Adipose Tissue undergoes pathological perturbations and shapes C2C12 myoblast homeostasis in the SOD1-G93A mouse model of Amyotrophic Lateral Sclerosis
Animal Study on Neuroinflammation, published in Heliyon (2025) — summary generated from the PubMed abstract.
- 2025
Heliyon - Level DNarrative ReviewEurope PMC
Neuroinflammation and Amyotrophic Lateral Sclerosis: Recent Advances in Anti-Inflammatory Cytokines as Therapeutic Strategies
Narrative Review on Neuroinflammation, Chronic Inflammation, published in Int J Mol Sci (2025) — summary generated from the PubMed abstract.
- 2025
Int J Mol Sci9 citations - Level BRandomized Controlled TrialPubMed
Adipose-derived mesenchymal stem cells for the treatment of Amyotrophic Lateral Sclerosis. A phase I/II safety and efficacy clinical trial.
Randomized Controlled Trial with a reported sample of 40 on Neuroinflammation, published in Front Neurol (2025) — summary generated from the PubMed abstract.
- 2025
- n = 40
Front Neurol - Level DNarrative ReviewEurope PMC
Advances in Induced Pluripotent Stem Cell Reprogramming and Its Application in Amyotrophic Lateral Sclerosis: A Review
Narrative Review on Neuroinflammation, published in FASEB Bioadv (2025) — summary generated from the PubMed abstract.
- 2025
FASEB Bioadv - Level BClinical TrialEurope PMC
Cutting-edge treatments in amyotrophic lateral sclerosis: the role of molecular pathogenesis in targeted therapies
Clinical Trial on Neuroinflammation, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
- 2025
Stem Cell Res Ther1 citations - Level DNarrative ReviewEurope PMC
Molecular hallmarks of ageing in amyotrophic lateral sclerosis
Narrative Review on Neuroinflammation, published in Cell Mol Life Sci (2024) — summary generated from the PubMed abstract.
- 2024
Cell Mol Life Sci22 citations - Level DLaboratory StudyPubMed
A Cellular Model of Amyotrophic Lateral Sclerosis to Study the Therapeutic Effects of Extracellular Vesicles from Adipose Mesenchymal Stem Cells on Microglial Activation.
Laboratory Study on Neuroinflammation, Chronic Inflammation, Immune Modulation, published in Int J Mol Sci (2024) — summary generated from the PubMed abstract.
- 2024
Int J Mol Sci5 citations - Level CRetrospective StudyEurope PMC
SHED-CM: The Safety and Efficacy of Conditioned Media from Human Exfoliated Deciduous Teeth Stem Cells in Amyotrophic Lateral Sclerosis Treatment: A Retrospective Cohort Analysis
Retrospective Study with a reported sample of 24 on Neuroinflammation, published in Biomedicines (2024) — summary generated from the PubMed abstract.
- 2024
- n = 24
Biomedicines3 citations - Level DLaboratory StudyEurope PMC
n-Butylidenephthalide recovered calcium homeostasis to ameliorate neurodegeneration of motor neurons derived from amyotrophic lateral sclerosis iPSCs
Laboratory Study on Neuroinflammation, published in PLoS One (2024) — summary generated from the PubMed abstract.
- 2024
PLoS One - Level BClinical TrialEurope PMC
Stem Cell Therapy for the Treatment of Amyotrophic Lateral Sclerosis: Comparison of the Efficacy of Mesenchymal Stem Cells, Neural Stem Cells, and Induced Pluripotent Stem Cells
Clinical Trial with a reported sample of 42 on Neuroinflammation, published in Biomedicines (2024) — summary generated from the PubMed abstract.
- 2024
- n = 42
Biomedicines9 citations - Level DNarrative ReviewEurope PMC
Recent Advances in Extracellular Vesicles in Amyotrophic Lateral Sclerosis and Emergent Perspectives
Narrative Review on Neuroinflammation, published in Cells (2023) — summary generated from the PubMed abstract.
- 2023
Cells18 citations - Level DAnimal StudyEurope PMC
Transplantation of Human Glial Progenitors to Immunodeficient Neonatal Mice with Amyotrophic Lateral Sclerosis (SOD1/rag2)
Animal Study on Neuroinflammation, published in Antioxidants (Basel) (2022) — summary generated from the PubMed abstract.
- 2022
Antioxidants (Basel)6 citations - Level DNarrative ReviewEurope PMC
Extracellular Vesicles in Amyotrophic Lateral Sclerosis
Narrative Review on Neuroinflammation, published in Life (Basel) (2022) — summary generated from the PubMed abstract.
- 2022
Life (Basel)30 citations - Level DNarrative ReviewEurope PMC
Extracellular vesicles and amyotrophic lateral sclerosis: from misfolded protein vehicles to promising clinical biomarkers
Narrative Review on Neuroinflammation, published in Cell Mol Life Sci (2021) — summary generated from the PubMed abstract.
- 2021
Cell Mol Life Sci56 citations - Level CCase Report / SeriesPubMed
Long-term survival of a patient with amyotrophic lateral sclerosis (ALS) who received autologous adipose-derived mesenchymal stem cells.
Case Report / Series on Neuroinflammation, published in Eur Rev Med Pharmacol Sci (2021) — summary generated from the PubMed abstract.
- 2021
Eur Rev Med Pharmacol Sci7 citations - Level DNarrative ReviewEurope PMC
Amyotrophic Lateral Sclerosis: Molecular Mechanisms, Biomarkers, and Therapeutic Strategies
Narrative Review on Neuroinflammation, published in Antioxidants (Basel) (2021) — summary generated from the PubMed abstract.
- 2021
Antioxidants (Basel)54 citations - Level DNarrative ReviewPubMed
Mesenchymal Stem Cells in Treatment of Spinal Cord Injury and Amyotrophic Lateral Sclerosis.
Narrative Review on Spinal Cord Injury, Neuroinflammation, Immune Modulation, published in Front Cell Dev Biol (2021) — summary generated from the PubMed abstract.
- 2021
Front Cell Dev Biol - Level DNarrative ReviewEurope PMC
A perspective on therapies for amyotrophic lateral sclerosis: can disease progression be curbed?
Narrative Review on Neuroinflammation, published in Transl Neurodegener (2021) — summary generated from the PubMed abstract.
- 2021
Transl Neurodegener52 citations - Level BClinical TrialPubMed
Safety and Efficacy of Allogeneic Adipose Tissue Mesenchymal Stromal Cells in Amyotrophic Lateral Sclerosis Patients, Single-Center, Prospective, Open-Label, Single-Arm Clinical Trial, Long-Term Follow-up.
Clinical Trial with a reported sample of 17 on Neuroinflammation, published in Cell J (2021) — summary generated from the PubMed abstract.
- 2021
- n = 17
Cell J7 citations - Level BClinical TrialEurope PMC
Mesenchymal Stem Cells: A Potential Therapeutic Approach for Amyotrophic Lateral Sclerosis?
Clinical Trial on Neuroinflammation, published in Stem Cells Int (2019) — summary generated from the PubMed abstract.
- 2019
Stem Cells Int38 citations - Level BClinical TrialEurope PMC
Stem cell treatments for amyotrophic lateral sclerosis: a critical overview of early phase trials
Clinical Trial on Neuroinflammation, published in Expert Opin Investig Drugs (2019) — summary generated from the PubMed abstract.
- 2019
Expert Opin Investig Drugs45 citations - Level CProspective StudyPubMed
Intraspinal Transplantation of the Adipose Tissue-Derived Regenerative Cells in Amyotrophic Lateral Sclerosis in Accordance with the Current Experts' Recommendations: Choosing Optimal Monitoring Tools.
Prospective Study on Neuroinflammation, published in Stem Cells Int (2018) — summary generated from the PubMed abstract.
- 2018
Stem Cells Int14 citations
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406